Abstract
Aim:
Quercetin and isorhamnetin are common constituents of some herb extracts, such as extracts of gingko leaves and total flavones of Hippophae rhamnoides L. The intra-herb pharmacokinetics interactions between isorhamnetin and quercetin were investigated in the present study.
Methods:
Human MDR1 cDNA transfected MDCKII cells were used to validate whether isorhamnein interacted with P-gp. Caco-2 transport assays and a randomized, 3-way crossover pharmacokinetics study in rats were used to investigate the pharmacokinetics interactions. HPLC was used to determine cell transport samples. The total plasma concentrations of quercetinand isorhamnetin were determined by liquid chromatography tandem mass spectrometry (LC-MS/MS) by treatment with β-glucuronidase and sulfatase.
Results:
The permeability ratio (absorptive permeability/secretive permeability) of isorhamnetin across human MDR1 cDNA transfected MDCKII cells, Caco-2 cells and wild-type MDCKII cells are 0.25±0.02, 0.74±0.05, and 1.41±0.06, respectively. This result proved the role of P-gp in the cell efflux of isorhamnetin. While co-transporting with each other across Caco-2 cells monolayer, the permeability ratio of isorhamnetin and quercetin increased by 4.3 and 2.2 times. After coadministration with each other to rats, the Cmax, AUC0–72 h, and AUC0–∞ of both isorhamnetin and quercetin significantly increased compared with single administration.
Conclusion:
The above results proved intra-herb pharmacokinetics interaction between quercetin and isorhamentin. P-gp might play an important role, whereas other drug efflux pumps, such as multi-drug resistance associate protein 2 and breast cancer resistance protein, might be involved. Accordingly, besides the drug-herb interactions, intra-herb interaction might be brought into view with the wide use of herbal-based remedies.
Similar content being viewed by others
Article PDF
References
Aruna D, Naidu MU . Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol 2007; 63: 333–8.
Meijerman I, Beijnen JH, Schellens JH . Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006; 11: 742–52.
Flanagan D . Understanding the grapefruit-drug interaction. Gen Dent 2005; 53: 282–5; quiz 286.
Brazier NC, Levine MA . Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 2003; 10: 163–9.
Oh SM, Chung KH . Estrogenic activities of Ginkgo biloba extracts. Life Sci 2004; 74: 1325–35.
Hibasami H, Mitani A, Katsuzaki H, Imai K, Yoshioka K, Komiya T . Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells. Int J Mol Med 2005; 15: 805–9.
Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C . Bioavailability of rutin and quercetin in rats. FEBS Lett 1997; 409: 12–16.
Ader P, Wessmann A, Wolffram S . Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000; 28: 1056–67.
Gugler R, Leschik M, Dengler HJ . Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975; 9: 229–34.
Cornish KM, Williamson G, Sanderson J . Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med 2002; 33: 63–70.
Formica JV, Regelson W . Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33: 1061–80.
Limtrakul P, Khantamat O, Pintha K . Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 2005; 17: 86–95.
Zhou S, Lim LY, Chowbay B . Herbal modulation of P-glycoprotein. Drug Metab Rev 2004; 36: 57–104.
Pal D, Mitra AK . MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 2006; 78: 2131–45.
Patel J, Buddha B, Dey S, Pal D, Mitra AK . In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 2004; 11: 262–77.
Wang Y, Cao J, Zeng S . Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 2005; 57: 751–8.
Fuller S, von Bonsdorff CH, Simons K . Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 1984; 38: 65–77.
Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P . Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer 2000; 83: 366–74.
Hammerle SP, Rothen-Rutishauser B, Kramer SD, Gunthert M, Wunderli-Allenspach H . P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope. Eur J Pharm Sci 2000; 12: 69–77.
Lan K, Jiang X, He J . Quantitative determination of isorhamnetin, quercetin and kaempferol in rat plasma by liquid chromatography with electrospray ionization tandem mass spectrometry and its application to the pharmacokinetic study of isorhamnetin. Rapid Commun Mass Spectrom 2007; 21: 112–20.
Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ . Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004; 36: 592–604.
Schulz HU, Schurer M, Bassler D, Weiser D . Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. Arzneimittelforschung 2005; 55: 561–8.
Schulz HU, Schurer M, Bassler D, Weiser D . Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Arzneimittelforschung 2005; 55: 15–22.
Braun A, Hammerle S, Suda K, Rothen-Rutishauser B, Gunthert M, Kramer SD, et al. Cell cultures as tools in biopharmacy. Eur J Pharm Sci 2000; 11 Suppl 2: S51–60.
Walgren RA, Kamaky KJ Jr, Lindenmayer GE, Walle T . Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 2000; 294: 830–6.
Xia CQ, Liu N, Yang D, Miwa G, Gan LS . Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab Dispos 2005; 33: 637–43.
Gant TW, Silverman JA, Thorgeirsson SS . Regulation of P-glyco-protein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res 1992; 20: 2841–6.
Lee CH, Bradley G, Zhang JT, Ling V . Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 1993; 157: 392–402.
Ader P, Block M, Pietzsch S, Wolffram S . Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett 2001; 162: 175–80.
Crespy V, Morand C, Besson C, Cotelle N, Vezin H, Demigne C, et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 2003; 284: G980–8.
Arts IC, Sesink AL, Faassen-Peters M, Hollman PC . The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br J Nutr 2004; 91: 841–7.
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA . Interaction of the breast cancer resistance protein with plant poly-phenols. Biochem Biophys Res Commun 2004; 317: 269–75.
Sesink AL, Arts IC, de Boer VC, Breedveld P, Schellens JH, Hollman PC, et al. Breast cancer resistance protein (Bcrpl/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 2005; 67: 1999–2006.
Walle T, Browning AM, Steed LL, Reed SG, Walle UK . Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 2005; 135: 48–52.
Schneider H, Simmering R, Hartmann L, Pforte H, Blaut M . Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 2000; 89: 1027–37.
O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G . Metabolism of quercetin-7- and quercetin-3-glu-curonides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003; 65: 479–91.
Wang Y, Cao J, Zeng S . Establishment of a P-glycoprotein substrate screening model and its preliminary application. World J Gastroenterol 2004; 10: 1365–8.
Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, et al. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 2000; 395: 193–201.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the National Natural Science Foundation of China (No 30572373).
Rights and permissions
About this article
Cite this article
Lan, K., He, Jl., Tian, Y. et al. Intra-herb pharmacokinetics interaction between quercetin and isorhamentin. Acta Pharmacol Sin 29, 1376–1382 (2008). https://doi.org/10.1111/j.1745-7254.2008.00884.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00884.x
Keywords
This article is cited by
-
A Double-Edged Sword: Focusing on Potential Drug-to-Drug Interactions of Quercetin
Revista Brasileira de Farmacognosia (2022)
-
Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin
European Journal of Drug Metabolism and Pharmacokinetics (2015)
-
Jiaotai pill (交泰丸) enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats
Chinese Journal of Integrative Medicine (2013)
-
Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs
Archives of Pharmacal Research (2012)
-
Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells
European Journal of Drug Metabolism and Pharmacokinetics (2011)